Pharmazz, Inc.
Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke.
All edits
Pharmazz, Inc.
Pharmazz is a Biopharmaceutical Company.
Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke.
Pharmazz, Inc.
Pharmazz is a Biopharmaceutical Company.
Pharmazz, Inc.
Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke.
Find more companies like Pharmazz, Inc.
